Meta facebook tracking pixel

Listen Now

Topics Covered

  • Review of Chronic Lymphocytic Leukemia (CLL), in the Context of COVID-19 & Its Variants
  • Significant Role of Testing in Informing Your Treatment Choices
  • First Line Treatment Options
  • Treatment of Relapsed & Refractory CLL
  • Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments
  • Current Perspectives on New & Emerging Treatments of CLL
  • Updates on Clinical Trials & Their Significance for CLL
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of OpenNotes
  • Practical Support to Cope with CLL
  • Questions for Our Panel of Experts

Our Panel of Experts


Mazyar Shadman, MD, MPH

Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, Associate Professor, Medical Oncology Division, University of Washington, Associate Professor, Attending Physician, Seattle Cancer Care Alliance


Adam S. Kittai, MD

Assistant Professor, Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center


Patricia Koffman

Co-Founder, CLL Society Inc.


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on September 08, 2022.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.